Vaccine-Associated Enhanced Disease and Pathogenic Human Coronaviruses
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vaccine-Associated Enhanced Disease and Pathogenic Human Coronaviruses
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-04-04
DOI
10.3389/fimmu.2022.882972
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
- (2022) Sandile Cele et al. NATURE
- Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants
- (2022) Catherine J. Reynolds et al. SCIENCE
- Advances and gaps in SARS-CoV-2 infection models
- (2022) César Muñoz-Fontela et al. PLoS Pathogens
- T cell responses to SARS-CoV-2 spike cross-recognize Omicron
- (2022) Roanne Keeton et al. NATURE
- Absence of vaccine-enhanced disease with unexpected positive protection against SARS-CoV-2 by inactivated vaccine given within three days of virus challenge in Syrian hamster model
- (2021) Can Li et al. CLINICAL INFECTIOUS DISEASES
- A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs
- (2021) Nanda Kishore Routhu et al. IMMUNITY
- Antibody-dependent enhancement of bacterial disease: Prevalence, mechanisms and treatment.
- (2021) Von Vergel L. Torres et al. INFECTION AND IMMUNITY
- Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
- (2021) Flor M. Munoz et al. VACCINE
- Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19
- (2021) Francisco J. Salguero et al. Nature Communications
- Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques
- (2021) Hyon-Xhi Tan et al. Nature Communications
- Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies
- (2021) Darrell O. Ricke Frontiers in Immunology
- Adjuvanting a subunit COVID-19 vaccine to induce protective immunity
- (2021) Prabhu S. Arunachalam et al. NATURE
- In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies
- (2021) Dapeng Li et al. CELL
- An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies
- (2021) Yafei Liu et al. CELL
- SARS-CoV-2-specific T cells in infection and vaccination
- (2021) Antonio Bertoletti et al. Cellular & Molecular Immunology
- Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey
- (2021) Mine Durusu Tanriover et al. LANCET
- Pan-Sarbecovirus Neutralizing Antibodies in BNT162b2-Immunized SARS-CoV-1 Survivors
- (2021) Chee-Wah Tan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
- (2021) Stephen J. Thomas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody fucosylation predicts disease severity in secondary dengue infection
- (2021) Stylianos Bournazos et al. SCIENCE
- Immune imprinting and SARS-CoV-2 vaccine design
- (2021) Adam K. Wheatley et al. TRENDS IN IMMUNOLOGY
- One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model
- (2021) Karen E. Gooch et al. VACCINE
- Immunological imprinting of the antibody response in COVID-19 patients
- (2021) Teresa Aydillo et al. Nature Communications
- Antibody-dependent enhancement representing in vitro infective progeny virus titer correlates with the viremia level in dengue patients
- (2021) Atsushi Yamanaka et al. Scientific Reports
- Macrophages and Dendritic Cells Are Not the Major Source of Pro-Inflammatory Cytokines Upon SARS-CoV-2 Infection
- (2021) Marc A. Niles et al. Frontiers in Immunology
- Immunological and pathological outcomes of SARS-CoV-2 challenge following formalin-inactivated vaccine in ferrets and rhesus macaques
- (2021) Kevin R. Bewley et al. Science Advances
- Filovirus Neutralising Antibodies: Mechanisms of Action and Therapeutic Application
- (2021) Alexander Hargreaves et al. Pathogens
- Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2
- (2021) Leo Swadling et al. NATURE
- Mechanisms of SARS-CoV-2 entry into cells
- (2021) Cody B. Jackson et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Inactivation of SARS-CoV-2 by β-propiolactone causes aggregation of viral particles and loss of antigenic potential
- (2021) Divya Gupta et al. VIRUS RESEARCH
- Antibody-Dependent Enhancement of SARS-CoV-2 Infection Is Mediated by the IgG Receptors FcγRIIA and FcγRIIIA but Does Not Contribute to Aberrant Cytokine Production by Macrophages
- (2021) Tadashi Maemura et al. mBio
- Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial
- (2021) Mohammad Bosaeed et al. Lancet Microbe
- SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues
- (2020) Carly G.K. Ziegler et al. CELL
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial
- (2020) Till Koch et al. LANCET INFECTIOUS DISEASES
- Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
- (2020) Pedro M Folegatti et al. LANCET INFECTIOUS DISEASES
- SARS-CoV-2 infection protects against rechallenge in rhesus macaques
- (2020) Abishek Chandrashekar et al. SCIENCE
- Rapid COVID-19 vaccine development
- (2020) Barney S. Graham SCIENCE
- Development of an inactivated vaccine candidate for SARS-CoV-2
- (2020) Qiang Gao et al. SCIENCE
- Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection
- (2020) Kun Li et al. mBio
- Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures
- (2020) Kenrie P Y Hui et al. Lancet Respiratory Medicine
- A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques
- (2020) Neeltje van Doremalen et al. Science Advances
- Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
- (2020) Hui Wang et al. CELL
- A perspective on potential antibody-dependent enhancement of SARS-CoV-2
- (2020) Ann M. Arvin et al. NATURE
- Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques
- (2020) Wei Deng et al. SCIENCE
- Antibody Dependent Enhancement Due to Original Antigenic Sin and the Development of SARS
- (2020) Walter Fierz et al. Frontiers in Immunology
- Animal models for COVID-19
- (2020) César Muñoz-Fontela et al. NATURE
- Immune Response Persistence and Safety of a Booster Dose of the Tetravalent Dengue Vaccine in Adolescents and Adults Who Previously Completed the 3-dose Schedule 4–5 Years Earlier in Latin America
- (2020) Diana Coronel et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity
- (2020) Angkana T. Huang et al. Nature Communications
- Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition
- (2020) Oliver C. Grant et al. Scientific Reports
- Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine
- (2020) Rahul Shukla et al. Frontiers in Cellular and Infection Microbiology
- Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies
- (2020) Wen Shi Lee et al. Nature Microbiology
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity
- (2020) Mads Delbo Larsen et al. SCIENCE
- Original Antigenic Sin: How First Exposure Shapes Lifelong Anti–Influenza Virus Immune Responses
- (2019) Ali Zhang et al. JOURNAL OF IMMUNOLOGY
- From therapeutic antibodies to immune complex vaccines
- (2019) Xuan-Yi Wang et al. npj Vaccines
- Understanding Fc Receptor Involvement in Inflammatory Diseases: From Mechanisms to New Therapeutic Tools
- (2019) Sanae Ben Mkaddem et al. Frontiers in Immunology
- Immunological Lessons from Respiratory Syncytial Virus Vaccine Development
- (2019) Tracy J. Ruckwardt et al. IMMUNITY
- Feline coronavirus with and without spike gene mutations detected by real-time RT-PCRs in cats with feline infectious peritonitis
- (2019) Laura Emmler et al. JOURNAL OF FELINE MEDICINE AND SURGERY
- Zika virus enhances monocyte adhesion and transmigration favoring viral dissemination to neural cells
- (2019) Nilda Vanesa Ayala-Nunez et al. Nature Communications
- Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
- (2019) Yushun Wan et al. JOURNAL OF VIROLOGY
- Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy
- (2018) Saranya Sridhar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of Antibody-Dependent Enhancement of SARS-CoV Infection in Rhesus Macaques Immunized with an Inactivated SARS-CoV Vaccine
- (2018) Fan Luo et al. VIROLOGICA SINICA
- Antibody-Dependent Enhancement of Ebola Virus Infection by Human Antibodies Isolated from Survivors
- (2018) Natalia A. Kuzmina et al. Cell Reports
- Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains
- (2017) Seth J. Zost et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Modulating IgG effector function by Fc glycan engineering
- (2017) Tiezheng Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antibody-dependent enhancement of severe dengue disease in humans
- (2017) Leah C. Katzelnick et al. SCIENCE
- Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
- (2017) Rudragouda Channappanavar et al. Seminars in Immunopathology
- Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody
- (2017) Katherine V. Houser et al. PLoS Pathogens
- Middle East respiratory syndrome coronavirus shows poor replication but significant induction of antiviral responses in human monocyte-derived macrophages and dendritic cells
- (2016) Janne Tynell et al. JOURNAL OF GENERAL VIROLOGY
- Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea
- (2016) Johan van Griensven et al. NEW ENGLAND JOURNAL OF MEDICINE
- Two-mAb cocktail protects macaques against the Makona variant of Ebola virus
- (2016) Xiangguo Qiu et al. Science Translational Medicine
- Vaccines against respiratory syncytial virus: The time has finally come
- (2016) Barney S. Graham VACCINE
- Ferret hepatitis E virus infection induces acute hepatitis and persistent infection in ferrets
- (2016) Tian-Cheng Li et al. VETERINARY MICROBIOLOGY
- Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus
- (2016) Anurodh Shankar Agrawal et al. Human Vaccines & Immunotherapeutics
- Modelling Virus and Antibody Dynamics during Dengue Virus Infection Suggests a Role for Antibody in Virus Clearance
- (2016) Hannah E Clapham et al. PLoS Computational Biology
- Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates
- (2016) Qidi Wang et al. ACS Infectious Diseases
- Antibody with an engineered Fc region as a therapeutic agent against dengue virus infection
- (2015) Ririn Ramadhany et al. ANTIVIRAL RESEARCH
- Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease
- (2015) Patricio L. Acosta et al. Clinical and Vaccine Immunology
- Understanding respiratory syncytial virus (RSV) vaccine development and aspects of disease pathogenesis
- (2015) Patricia A. Jorquera et al. Expert Review of Vaccines
- Chemical Cross-Linking Stabilizes Native-Like HIV-1 Envelope Glycoprotein Trimer Antigens
- (2015) Torben Schiffner et al. JOURNAL OF VIROLOGY
- Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein
- (2015) Asisa Volz et al. JOURNAL OF VIROLOGY
- An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels
- (2015) B. L. Haagmans et al. SCIENCE
- RSV Vaccine-Enhanced Disease Is Orchestrated by the Combined Actions of Distinct CD4 T Cell Subsets
- (2015) Cory J. Knudson et al. PLoS Pathogens
- Prior Immunization with Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-CoV) Nucleocapsid Protein Causes Severe Pneumonia in Mice Infected with SARS-CoV
- (2014) F. Yasui et al. JOURNAL OF IMMUNOLOGY
- Intranasal Vaccination of Recombinant Adeno-Associated Virus Encoding Receptor-Binding Domain of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Spike Protein Induces Strong Mucosal Immune Responses and Provides Long-Term Protection against SARS-CoV Infection
- (2014) L. Du et al. JOURNAL OF IMMUNOLOGY
- Effects of Toll-Like Receptor Stimulation on Eosinophilic Infiltration in Lungs of BALB/c Mice Immunized with UV-Inactivated Severe Acute Respiratory Syndrome-Related Coronavirus Vaccine
- (2014) N. Iwata-Yoshikawa et al. JOURNAL OF VIROLOGY
- Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
- (2014) Xiangguo Qiu et al. NATURE
- An update on feline infectious peritonitis: Virology and immunopathogenesis
- (2014) Niels C. Pedersen VETERINARY JOURNAL
- Phagocytic cells contribute to the antibody-mediated elimination of pulmonary-infected SARS coronavirus
- (2014) Fumihiko Yasui et al. VIROLOGY
- Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus
- (2014) Ming Yip et al. Virology Journal
- Active Replication of Middle East Respiratory Syndrome Coronavirus and Aberrant Induction of Inflammatory Cytokines and Chemokines in Human Macrophages: Implications for Pathogenesis
- (2013) Jie Zhou et al. JOURNAL OF INFECTIOUS DISEASES
- Middle East Respiratory Syndrome Coronavirus Spike Protein Delivered by Modified Vaccinia Virus Ankara Efficiently Induces Virus-Neutralizing Antibodies
- (2013) F. Song et al. JOURNAL OF VIROLOGY
- Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
- (2012) Chien-Te Tseng et al. PLoS One
- Successful Treatment of Ebola Virus-Infected Cynomolgus Macaques with Monoclonal Antibodies
- (2012) X. Qiu et al. Science Translational Medicine
- The role of non-viral antigens in the cotton rat model of respiratory syncytial virus vaccine-enhanced disease
- (2012) Christine A. Shaw et al. VACCINE
- Antibody-Dependent Enhancement of Marburg Virus Infection
- (2011) Eri Nakayama et al. JOURNAL OF INFECTIOUS DISEASES
- Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH- and Cysteine Protease-Independent Fc R Pathway
- (2011) M. Jaume et al. JOURNAL OF VIROLOGY
- A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response upon Challenge
- (2011) M. Bolles et al. JOURNAL OF VIROLOGY
- Lack of Original Antigenic Sin in Recall CD8+ T Cell Responses
- (2010) D. Zehn et al. JOURNAL OF IMMUNOLOGY
- Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes
- (2010) Scott B Halstead et al. LANCET INFECTIOUS DISEASES
- Antibody-Dependent Enhancement Occurs Upon Re-Infection with the Identical Serotype Virus in Feline Infectious Peritonitis Virus Infection
- (2009) Tomomi TAKANO et al. JOURNAL OF VETERINARY MEDICAL SCIENCE
- Ly6c+“inflammatory monocytes” are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis
- (2008) Daniel R. Getts et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease
- (2008) Maria Florencia Delgado et al. NATURE MEDICINE
- A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial
- (2008) Julie E. Martin et al. VACCINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started